IS A CONTROLLED TRIAL OF LONG-TERM ORAL ANTICOAGULANTS IN PATIENTS WITH STROKE AND NON-RHEUMATIC ATRIAL FIBRILLATION WORTHWHILE?
- 5 April 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 327 (8484) , 788-792
- https://doi.org/10.1016/s0140-6736(86)91794-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Non-rheumatic atrial fibrillation as a risk factor for stroke.Stroke, 1985
- Thromboembolism in Patients With Atrial FibrillationArchives of Neurology, 1984
- Incidence of stroke in Oxfordshire: first year's experience of a community stroke register.BMJ, 1983
- Duration of atrial fibrillation and imminence of stroke: the Framingham study.Stroke, 1983
- Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.Stroke, 1983
- Anticoagulation therapy for cardiogenic emboli to brainNeurology, 1982
- Management of cerebral embolism of cardiac origin.Stroke, 1980
- Epidemiologic assessment of chronic atrial fibrillation and risk of strokeNeurology, 1978
- XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.Stroke, 1977
- Anticoagulant therapy in cerebral infarctionNeurology, 1962